Biopharmaceutical company Seelos Therapeutics, Inc. (SEEL) announced Monday the appointment of Richard Pascoe as Chairman of the Board of Directors of Seelos to lead the ongoing strategic process and business development discussions and negotiations.Pascoe has served as member of the Seelos board since 2019.

生物制药公司Seelos Therapeutics，Inc.（SEEL）周一宣布任命理查德·帕斯科（Richard Pascoe）为Seelos董事会主席，负责领导正在进行的战略流程和业务发展讨论与谈判。自2019年以来，帕斯科一直担任Seelos董事会成员。

For comments and feedback contact: editorial@rttnews.comBusiness News.

如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision in March 2024

2024年3月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In November 2023

2023年11月美国食品和药物管理局（FDA）决定生物技术股